Deerfield Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-812,408
| Closed | -$8.5M | – | 139 |
|
|
2025
Q1 | $8.5M | Buy |
812,408
+376,755
| +86% | +$3.94M | 0.17% | 71 |
|
|
2024
Q4 | $10.3M | Hold |
435,653
| – | – | 0.19% | 64 |
|
|
2024
Q3 | $15.6M | Buy |
+435,653
| New | +$15.6M | 0.23% | 57 |
|
|
2024
Q2 | – | Sell |
-7,940
| Closed | -$225K | – | 474 |
|
|
2024
Q1 | $225K | Buy |
+7,940
| New | +$225K | ﹤0.01% | 314 |
|
|
2021
Q3 | – | Sell |
-787,000
| Closed | -$16.6M | – | 140 |
|
|
2021
Q2 | $16.6M | Buy |
787,000
+101,000
| +15% | +$2.12M | 0.29% | 90 |
|
|
2021
Q1 | $10.7M | Buy |
686,000
+116,000
| +20% | +$1.8M | 0.22% | 98 |
|
|
2020
Q4 | $12M | Buy |
570,000
+158,733
| +39% | +$3.33M | 0.24% | 94 |
|
|
2020
Q3 | $8.3M | Buy |
+411,267
| New | +$8.3M | 0.2% | 88 |
|